Efficacy of Lopinavir–Ritonavir Combination Therapy for the Treatment of Hospitalized COVID-19 Patients: A Meta-Analysis
Jiawen Deng, Fangwen Zhou, Wenteng Hou, Kiyan Heybati, Saif Ali, Oswin Chang, Zachary Silver, Thanansayan Dhivagaran, Harikrishnaa Ba Ramaraju, Chi Yi Wong, Qi Zuo, Elizabeth Lapshina, Madeline Mellett
Abstract
Given the lack of efficacy and increased incidence of adverse events, the clinical use of LPV/r in hospitalized COVID-19 patients is not recommended.
Topics & Concepts
LopinavirMedicineLopinavir/ritonavirMeta-analysisRitonavirAdverse effectIncidence (geometry)Internal medicineCoronavirus disease 2019 (COVID-19)Odds ratioObservational studyRandomized controlled trialMechanical ventilationViral loadVirologyHuman immunodeficiency virus (HIV)Antiretroviral therapyOpticsInfectious disease (medical specialty)PhysicsDiseaseCOVID-19 Clinical Research StudiesAntibiotics Pharmacokinetics and EfficacyInfectious Encephalopathies and Encephalitis